The Digitalization and AI presence in the Global Biopharma Industry, valued at USD 1784.1 Million in 2022, is projected to reach $2.47 Billion by 2027, with a robust growth rate exceeding 5.7% from 2023 to 2030. This growth is particularly notable in the APAC region, where governments are offering strategic incentives for biomanufacturing and technology adoption.
Following its successful inaugural edition, the Biologics Digitalization & AI World conference returns on March 12th and 13th, serving as a platform for Biologics sector leaders in APAC to showcase how their pioneering adoption of AI and digitalization across various aspects of BioPharma has improved process efficiency, enhanced productivity, reduced costs, and maintained top-tier quality.
Find out more here, https://www.imapac.com/events/biologics-digitalization-ai-world-2025 .
